Mark Cuban Cost Plus Drug Company PBC Revenue and Competitors
Estimated Revenue & Valuation
- Mark Cuban Cost Plus Drug Company PBC's estimated annual revenue is currently $15.3M per year.
- Mark Cuban Cost Plus Drug Company PBC's estimated revenue per employee is $201,000
Employee Data
- Mark Cuban Cost Plus Drug Company PBC has 76 Employees.
- Mark Cuban Cost Plus Drug Company PBC grew their employee count by 21% last year.
Mark Cuban Cost Plus Drug Company PBC's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO / Co-Founder | Reveal Email/Phone |
2 | VP Manufacturing Operations | Reveal Email/Phone |
3 | VP - Commercial Operations | Reveal Email/Phone |
4 | VP Quality and Safety | Reveal Email/Phone |
5 | VP Engineering & Facilities and Construction Management | Reveal Email/Phone |
6 | EVP, Procurement & Supply Chain | Reveal Email/Phone |
7 | Senior Human Resources Manager | Reveal Email/Phone |
8 | Licensing Specialist | Reveal Email/Phone |
Mark Cuban Cost Plus Drug Company PBC Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $26.7M | 133 | 20% | N/A | N/A |
#2 | $13.5M | 67 | 6% | N/A | N/A |
#3 | $16.1M | 80 | -2% | N/A | N/A |
#4 | $62.5M | 0 | N/A | N/A | N/A |
#5 | $10.1M | 50 | 6% | N/A | N/A |
#6 | $119.4M | 594 | 27% | N/A | N/A |
#7 | $22.9M | 114 | 8% | N/A | N/A |
#8 | $92.9M | 462 | 8% | N/A | N/A |
#9 | $11.3M | 56 | -8% | N/A | N/A |
#10 | $7M | 35 | 6% | N/A | N/A |
What Is Mark Cuban Cost Plus Drug Company PBC?
We’re making and selling medicines at fixed, transparent profit margins to provide an affordable option for patients left behind by market and regulatory forces. We are working to end unnecessary drug shortages in the United States.
keywords:N/AN/A
Total Funding
76
Number of Employees
$15.3M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $13.7M | 76 | 9% | N/A |
#2 | $20.5M | 76 | -5% | N/A |
#3 | $20.5M | 76 | 3% | N/A |
#4 | $7.6M | 76 | 6% | N/A |
#5 | $11M | 76 | 12% | $24.2M |